BIOMARKER:

EMT gene signature

EMT gene signature EMT gene signature	Non Small Cell Lung Cancer NSCLC	EMT gene signature EMT gene signature	Non Small Cell Lung Cancer NSCLC	nivolumab Sensitive: C3 – Early Trials	nivolumab Sensitive: C3 – Early Trials
EMT gene signature EMT gene signature	Non Small Cell Lung Cancer NSCLC	EMT gene signature EMT gene signature	Non Small Cell Lung Cancer NSCLC	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials

Associations